- Home
- UPLD vs MURA Comparison
UPLD vs MURA Comparison
Compare UPLD & MURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UPLD
- MURA
- Stock Information
- Founded
- UPLD 2010
- MURA 2013
- Country
- UPLD United States
- MURA Ireland
- Employees
- UPLD 998
- MURA N/A
- Industry
- UPLD Computer Software: Prepackaged Software
- MURA
- Sector
- UPLD Technology
- MURA
- Exchange
- UPLD Nasdaq
- MURA Nasdaq
- Market Cap
- UPLD 51.0M
- MURA 45.8M
- IPO Year
- UPLD 2014
- MURA N/A
- Fundamental
- Price
- UPLD $1.74
- MURA $2.48
- Analyst Decision
- UPLD Hold
- MURA Strong Buy
- Analyst Count
- UPLD 1
- MURA 3
- Target Price
- UPLD N/A
- MURA $12.00
- AVG Volume (30 Days)
- UPLD 155.1K
- MURA 100.7K
- Earning Date
- UPLD 07-31-2025
- MURA 08-12-2025
- Dividend Yield
- UPLD N/A
- MURA N/A
- EPS Growth
- UPLD N/A
- MURA N/A
- EPS
- UPLD N/A
- MURA N/A
- Revenue
- UPLD $267,713,000.00
- MURA N/A
- Revenue This Year
- UPLD N/A
- MURA N/A
- Revenue Next Year
- UPLD N/A
- MURA N/A
- P/E Ratio
- UPLD N/A
- MURA N/A
- Revenue Growth
- UPLD N/A
- MURA N/A
- 52 Week Low
- UPLD $1.69
- MURA $0.95
- 52 Week High
- UPLD $5.64
- MURA $4.74
- Technical
- Relative Strength Index (RSI)
- UPLD 36.73
- MURA 45.72
- Support Level
- UPLD $1.70
- MURA $2.41
- Resistance Level
- UPLD $1.85
- MURA $2.55
- Average True Range (ATR)
- UPLD 0.11
- MURA 0.09
- MACD
- UPLD 0.02
- MURA -0.01
- Stochastic Oscillator
- UPLD 34.62
- MURA 28.57
About UPLD Upland Software Inc.
Upland Software Inc is a software company. It provides cloud-based software applications in three categories: Knowledge Management that provides solutions designed to help organizations capture, organize, and distribute information to employees and customers. Content Lifecycle and Workflow Automation offers solutions that support document management, compliance, and process efficiency across various industries. Digital Marketing solutions that provides tools for audience engagement, campaign management, and content distribution across digital channels.
About MURA Mural Oncology plc
Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.